The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns and real-world effectiveness of rituximab maintenance in older patients with mantle cell lymphoma: A population-based analyses.
 
Mengyang Di
No Relationships to Disclose
 
Jessica B. Long
Employment - Kindred at Home (I)
 
Shalin Kothari
Consulting or Advisory Role - Karyopharm Therapeutics
 
Tarsheen Kaur Sethi
No Relationships to Disclose
 
Amer Methqal Zeidan
Honoraria - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Consulting or Advisory Role - Abbvie; Acceleron Pharma; Agios; Astellas Pharma; BeyondSpring Pharmaceuticals; Boehringer Ingelheim; Bristol-Myers Squibb; Cardinal Health; Celgene; Daiichi Sankyo; Epizyme; Incyte; Ionis Pharmaceuticals; Jazz Pharmaceuticals; Novartis; Otsuka; Pfizer; Seagen; Taiho Pharmaceutical; Takeda; Trovagene
Research Funding - Abbvie (Inst); ADC Therapeutics (Inst); Aprea AB (Inst); Astex Pharmaceuticals (Inst); AstraZeneca/MedImmune (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Incyte (Inst); Novartis (Inst); Pfizer (Inst); Takeda (Inst); Trovagene (Inst)
Travel, Accommodations, Expenses - Celgene; Novartis; Pfizer; Trovagene
 
Nikolai Alexandrovich Podoltsev
Honoraria - Abbvie; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Cogent Biosciences; Constellation Pharmaceuticals; CTI BioPharma Corp; Incyte; Novartis; PharmaEssentia
Consulting or Advisory Role - Abbvie; Blueprint Medicines; Bristol-Myers Squibb; Celgene; Cogent Biosciences; Constellation Pharmaceuticals; CTI BioPharma Corp; Incyte; Novartis; PharmaEssentia
Research Funding - AI Therapeutics (Inst); Arog (Inst); Astellas Pharma (Inst); Astex Pharmaceuticals (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); CTI BioPharma Corp (Inst); Daiichi Sankyo (Inst); Genentech (Inst); Jazz Pharmaceuticals (Inst); Kartos Therapeutics (Inst); Pfizer (Inst); Samus Therapeutics (Inst); Sunesis Pharmaceuticals (Inst)
 
Rory Shallis
Stock and Other Ownership Interests - Curis
Consulting or Advisory Role - Bristol-Myers Squibb/Pfizer
 
Rong Wang
Research Funding - Cellgen (Inst)
 
Xiaomei Ma
Consulting or Advisory Role - Bristol-Myers Squibb/Celgene
Research Funding - Bristol-Myers Squibb/Celgene (Inst)
 
Scott F. Huntington
Honoraria - AstraZeneca; Pharmacyclics; Seagen
Consulting or Advisory Role - Abbvie; ADC Therapeutics; AstraZeneca; Bayer; BeiGene; Epizyme; Flatiron Health; Genentech; Janssen; Merck; Novartis; Seagen; TG Therapeutics; Tyme Inc.
Research Funding - Agios; Celgene; Debiopharm Group; DTRM; TG Therapeutics
Travel, Accommodations, Expenses - Bayer; Celgene; Genentech; Pharmacyclics